Slideshow

12 Recommendations for Osteoporosis Treatment

Author(s):

Shared decision making should be employed in deciding on the best course of treatment for postmenopausal women with osteoporosis, experts say. In this slideshow, we highlight some of the key recommendations for diagnosing osteoporosis and assessing fracture risk in postmenopausal women.

Shared decision making should be employed in deciding on the best course of treatment for postmenopausal women with osteoporosis, experts say.This advice comes from the authors of the 2016 guidelines for the diagnosis and treatment of postmenopausal osteoporosis by the American Association of Clinical Endocrinologists and the American College of Endocrinology. A key to successful treatment, they write, is a sound treatment plan embraced by both doctor and patient."It is incumbent upon the clinician to provide this information to patients in a manner that is fully understood, and it is equally important to learn from the patient about cultural beliefs, previous treatment experiences, fears and concerns. With effective risk communication, the clinician and the patient are both privy to the same information. This is the first step toward shared decision-making,  a process by which a management plan is developed with active patient participation," write Pauline M. Camacho, M.D., FACE, and colleagues in the guidelines.Patient-doctor communication isn’t easy, they write. Risks that may seem trivial to a doctor, may not be so trivial to a patient.In this slideshow, we highlight some of the key recommendations for diagnosing osteoporosis and assessing fracture risk in postmenopausal women.

References:

American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis – 2106. Endocrine Practice. September 2016. https://www.aace.com/files/postmenopausal-guidelines.pdf

Related Videos
Diabetes Dialogue: Exploring New Horizons in Incretin Therapy for Diabetes and Weight Loss | Image Credit: HCPLive
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.